EUVIMEDEUVIMED entdecken
Crossref

LEF1 Suppresses Ferroptosis in Colorectal Cancer Cells by Targeted Promotion of SLC7A11 Transcription

Yanan Chen, Zhennan Ma iD, Xiuqing Gong

The FASEB Journal · 2025

DOI: 10.1096/fj.202502018r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Yanan Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Shenyang Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Ferroptosis, Colorectal Neoplasms, Lymphoid Enhancer-Binding Factor 1, Amino Acid Transport System y+. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Dalian Life and Health Sector Mentoring Programme Project, Natural Science Foundation-Doctoral Research Initiation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis has emerged as a promising therapeutic target for colorectal cancer (CRC) due to its ability to selectively eliminate cancer cells. By inducing ferroptosis, novel treatment strategies aim to overcome traditional challenges such as cancer recurrence and drug resistance. In this study, we screened cells with high LEF1 expression, knocked down LEF1, or simultaneously overexpressed SLC7A11 in these cells, and intervened with ferroptosis inducers and inhibitors to investigate the mechanism of LEF1 in inhibiting ferroptosis and promoting CRC cell growth. Dual‐luciferase reporter assays and CHIP‐qPCR were utilized to validate the effect of LEF1 on SLC7A11 transcription. Furthermore, a nude mouse subcutaneous xenograft model was established using CRC cells with stable LEF1 knockdown to verify the impact of LEF1 on CRC tumor growth in vivo. Our findings indicate that LEF1 knockdown inhibits CRC cell progression both in vitro and in vivo. Moreover, we discovered that the molecular mechanism underlying the role of LEF1 is the targeted activation of SLC7A11 transcription, which alleviates ferroptosis, ultimately leading to CRC progression. Our results suggest that LEF1 inhibits ferroptosis in CRC cells by promoting SLC7A11 transcription, potentially serving as a therapeutic target for CRC. This study reveals that the promotion of CRC by LEF1 is associated with activating SLC7A11 transcription and inhibiting cellular ferroptosis, providing a new direction for clinical targeted therapy of CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisColorectal NeoplasmsLymphoid Enhancer-Binding Factor 1Amino Acid Transport System y+Gene Expression Regulation, NeoplasticTranscription, GeneticHumansAnimalsMiceMice, NudeCell Line, TumorMice, Inbred BALB CXenograft Model Antitumor AssaysCell Proliferation

Stichwörter der Autor:innen

LEF1SLC7A11colorectal cancererastinferroptosis

Substanzen

Lymphoid Enhancer-Binding Factor 1Amino Acid Transport System y+LEF1 protein, humanSLC7A11 protein, human

Autor:innen und Institutionen

  • Graduate School of Shenyang Medical University, Shenyang, China.
  • Three Wards of Anorectal Surgery, Dalian University Affiliated Xinhua Hospital, Dalian, China.
  • Maternity Ward One, Dalian Women and Children's Medical Group, Dalian, China.

ORCID-Profile: Zhennan Ma

Förderung

  • Dalian Life and Health Sector Mentoring Programme Project
  • Natural Science Foundation-Doctoral Research Initiation Program

Zitieren

APA

Chen, Y., Ma, Z., & Gong, X. (2025). LEF1 Suppresses Ferroptosis in Colorectal Cancer Cells by Targeted Promotion of SLC7A11 Transcription. The FASEB Journal. https://doi.org/10.1096/fj.202502018r

Vancouver

Chen Y, Ma Z, Gong X. LEF1 Suppresses Ferroptosis in Colorectal Cancer Cells by Targeted Promotion of SLC7A11 Transcription. The FASEB Journal. 2025. doi:10.1096/fj.202502018r

BibTeX
@article{Chen2025,
  author = {Chen, Yanan and Ma, Zhennan and Gong, Xiuqing},
  title = {LEF1 Suppresses Ferroptosis in Colorectal Cancer Cells by Targeted Promotion of SLC7A11 Transcription},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202502018r}
}
Kostenlos starten →